Evidence map›Paper›PMID 41932997›Full record

ArticleScientific reports2026

Proteomic signatures in cerebrospinal fluid and their clinical associations in patients with ME/CFS.

Björn Bragée, Peng Li, Danielle Meadows, Anna Widgren, Per Sjögren, Per Hamid Ghatan, Bo C Bertilson, Wenzhong Xiao, Jonas Bergquist

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Björn Bragée *ME Center, Bragée Clinics, Stockholm, Sweden.
Peng Li *The Open Medicine Foundation Computational Research Center for Complex Chronic Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Danielle MeadowsThe Open Medicine Foundation, Agoura Hills, CA, USA.
Anna WidgrenAnalytical Chemistry and Neurochemistry, Department of Chemistry for Life Sciences, BMC, Uppsala University, Box 599, Uppsala, Sweden.
Per SjögrenME Center, Bragée Clinics, Stockholm, Sweden.
Per Hamid GhatanME Center, Bragée Clinics, Stockholm, Sweden.
Bo C BertilsonME Center, Bragée Clinics, Stockholm, Sweden.
Wenzhong XiaoThe Open Medicine Foundation Computational Research Center for Complex Chronic Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. wenzhong.xiao@mgh.harvard.edu.
Jonas BergquistAnalytical Chemistry and Neurochemistry, Department of Chemistry for Life Sciences, BMC, Uppsala University, Box 599, Uppsala, Sweden. jonas.bergquist@kemi.uu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated the cerebrospinal fluid (CSF) proteomes from 31 patients diagnosed with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). We quantified 902 proteins, each expressed in at least eleven samples, and systematically categorized clinical factors relevant to ME/CFS symptoms-including autonomic dysfunction, neuroinflammation and metabolic disturbances. Differentially expressed protein and pathway analyses evaluated protein features associated with both postural orthostatic tachycardia syndrome (POTS) status and disease severity among the patients, while ratio-based analysis further explored associations with severity ratings. Data are available via ProteomeXchange with identifier PXD076216. Neutrophil degranulation and platelet activation were enriched in patients with POTS, and several pathways, such as the complement cascade, coagulation-related pathways and IGFBP‑mediated insulin-like growth factor transport, were enriched in severe cases. Ratio-based analysis identified four biologically interpretable severity-associated protein ratios related to cellular stress, extracellular remodelling and immune-neuronal interaction. Together, these findings provide insight into the biological processes associated with clinical heterogeneity in ME/CFS and generate hypotheses for future validation in larger independent cohorts.

Indexed as

Fatigue Syndrome, ChronicProteomeProteomicsAdultBiomarkersFemaleHumansMaleMiddle AgedPostural Orthostatic Tachycardia SyndromeSeverity of Illness IndexBiomarkersProteomeCerebrospinal fluid proteomicsDisease severity biomarkersMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)Postural orthostatic tachycardia syndrome (POTS)

Identifiers

PMID41932997
PMCPMC13194927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.